Reaktion #10466

ord-d8b72c473c3d4b2989a2714c082313d6

Reaktionsgleichung

Cc1c(Cl)cccc1S(=O)(=O)Nc1ncc(CC(=O)O)s1
(2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetic acid
CCN=C=NCCCN(C)C
EDCI
CCN(CC)CC
triethylamine
C1COCCN1
morpholine
Cc1c(Cl)cccc1S(=O)(=O)Nc1ncc(CC(=O)N2CCOCC2)s1
desired product
Ausbeute 10.0%
Cc1c(Cl)cccc1S(=O)(=O)Nc1ncc(CC(=O)N2CCOCC2)s1
3-chloro-2-methyl-N-[5-(2-morpholin-4-yl-2-oxoethyl)-1,3-thiazol-2yl]benzenesulfonamide
Ausbeute 10.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    WaschenThe reaction mixture was then washed with 1 M HCl (2×15 mL)
  2. 2
    Sonstigethe organic layer was collected
  3. 3
    TrocknenThe organic phase was dried (MgSO4)
  4. 4
    Einengenconcentrated under reduced pressure
  5. 5
    SonstigePurification

Vorschrift

To a solution of (2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetic acid (Example 3) (0.09 g, 0.25 mmol) in CH2Cl2 (5.0 mL) and DMF (0.5 mL) were added EDCI (0.05 g, 0.27 mmol), DMAP (0.02 g, 0.12 mmol), triethylamine (0.1 mL, 0.75 mmol) and morpholine (0.03 mL, 0.30 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was then washed with 1 M HCl (2×15 mL) and the organic layer was collected. The organic phase was dried (MgSO4) and concentrated under reduced pressure. Purification using preparative HPLC afforded the desired product (0.01 g) in 10% yield.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07094792B2uspto-grants-2006_08